Application 207956
- Type
- ANDA
- Sponsor
- LABORATORIOS GRIFOLS
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | SODIUM CHLORIDE | INJECTABLE;INJECTION | 900MG/100ML | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 51662-1609 | 0.9% SODIUM CHLORIDE | 0.9% SODIUM CHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | ANDA | Current |
| 76297-001 | Sodium Chloride | Sodium Chloride | LABORATORIOS GRIFOLS SA | ANDA | Current |
| 76297-001 | Sodium Chloride | Sodium Chloride | LABORATORIOS GRIFOLS SA | ANDA | Current |
| 76297-001 | Sodium Chloride | Sodium Chloride | LABORATORIOS GRIFOLS SA | ANDA | Current |
| 76297-001 | Sodium Chloride | Sodium Chloride | LABORATORIOS GRIFOLS SA | ANDA | Current |
| 76297-001 | Sodium Chloride | Sodium Chloride | LABORATORIOS GRIFOLS SA | ANDA | Current |
| 76297-001 | Sodium Chloride | Sodium Chloride | LABORATORIOS GRIFOLS SA | ANDA | Current |
| 79672-613 | Sodium Chloride | SODIUM CHLORIDE | Nextgen Pharmaceuticals LLC | ANDA | Current |
| 79672-613 | Sodium Chloride | SODIUM CHLORIDE | Nextgen Pharmaceuticals LLC | ANDA | Current |
| 79672-613 | Sodium Chloride | SODIUM CHLORIDE | Nextgen Pharmaceuticals LLC | ANDA | Current |
| 79672-613 | Sodium Chloride | SODIUM CHLORIDE | Nextgen Pharmaceuticals LLC | ANDA | Current |
| 79672-613 | Sodium Chloride | SODIUM CHLORIDE | Nextgen Pharmaceuticals LLC | ANDA | Current |
| 79672-613 | Sodium Chloride | SODIUM CHLORIDE | Nextgen Pharmaceuticals LLC | ANDA | Current |
| 81826-001 | Sodium Chloride | SODIUM CHLORIDE | CODAN US CORPORATION | ANDA | Current |